{"transactions":[{"id":778889,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:45:40.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010750","document":"treco-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010750/treco-form4_051426.xml","form_type":"4"}},{"id":1060142,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-08-20T20:15:15.000Z","date":"2025-08-20","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":36,"value":9000.0,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0001999371-25-011754","document":"treco-form4_082025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125011754/treco-form4_082025.xml","form_type":"4"}},{"id":1147251,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T21:04:29.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006255","document":"treco-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006255/treco-form4.xml","form_type":"4"}},{"id":1238301,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:31:48.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.02,"price":0.3,"value":0.006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012472","document":"treco-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012472/treco-form4_022825.xml","form_type":"4"}},{"id":1501833,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:10:58.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006625","document":"treco-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006625/treco-form4.xml","form_type":"4"}},{"id":1898032,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:01:11.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001387131-23-006320","document":"treco-form4_050823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123006320/treco-form4_050823.xml","form_type":"4"}},{"id":2274654,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:38:45.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006014/ownership.xml","form_type":"4"}},{"id":2716248,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-05-12T20:45:25.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":270882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":270882,"derivative":{"exercise_price":1.03,"exercise_date":"2022-05-10","expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":270882},"source":{"system":"sec-edgar","filing":"0001387131-21-005548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121005548/ownership.xml","form_type":"4"}},{"id":3042524,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2020-09-01T13:03:19.000Z","date":"2020-08-31","kind":"purchase","acquired":true,"shares":5500,"price":0.89,"value":4895.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001387131-20-008117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120008117/ownership.xml","form_type":"4"}},{"id":3055827,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2020-08-17T13:06:58.000Z","date":"2020-08-14","kind":"purchase","acquired":true,"shares":4500,"price":1.06,"value":4770.0,"ownership":{"direct":true},"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001387131-20-007594","document":"treco-form4_081420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120007594/treco-form4_081420.xml","form_type":"4"}},{"id":3159352,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-06T22:33:39.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":112500,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001387131-20-004493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004493/ownership.xml","form_type":"4"}},{"id":3202383,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-18T20:00:41.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."}],"balance_after":6000,"derivative":{"exercise_price":0.53,"exercise_date":"2021-03-16","expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001387131-20-002994","document":"treco-form4_031620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120002994/treco-form4_031620.xml","form_type":"4"}},{"id":3535054,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T11:21:08.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001387131-19-003411","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003411/ownership.xml","form_type":"4"}},{"id":3649621,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-02-19T21:54:33.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 14, 2019 pursuant to the Issuer's 2018 Equity Incentive Plan and vests on the date of the Issuer's 2019 annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":1.86,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001387131-19-001333","document":"treco-form4_021419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119001333/treco-form4_021419.xml","form_type":"4"}}]}